Triple Antibiotic
- Product NDC
- 47682-392
- 11-digit product format
- 476820392
- Labeler code
- 47682
- Product ID
- 47682-392_3e4ee639-9af3-38c5-e063-6394a90a9ad3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- bacitracin zinc, neomycin sulfate, polymyxin b sulfate
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Unifirst First Aid Corporation
- Application
- M004
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2013-04-12
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
- Active strength
- 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 47682-392 | 47682-392-12 | D | Discontinued by firm | 2026-10-12 | |
| excluded package | package | 47682-392 | 47682-392-71 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 47682-392-12 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 47682-392-71 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 47682-392-71 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 47682-392-12 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 47682-392-71 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 47682-392-12 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 47682-392-71 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 47682-392-12 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 47682-392-71 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 47682-392-12 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 47682-392-71 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 47682-392-12 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 47682-392-71 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 47682-392-12 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 47682-392-71 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 47682-392-12 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 47682-392-71 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 47682-392-12 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 47682-392-71 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 47682-392-12 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 47682-392-71 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 47682-392-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 47682-392-71 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 47682-392-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Triple Antibiotic
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BACITRACIN ZINC | 400 [USP'U]/g |
| NEOMYCIN SULFATE | 3.5 mg/g |
| POLYMYXIN B SULFATE | 5000 [USP'U]/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89Y4M234ES | Internal UNII lookup |
| 057Y626693 | Internal UNII lookup |
| 19371312D4 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 204602 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 99e684e6-f435-feb8-d2bb-3a546f1cb768 | Product name | 2 | 20161117 |
| 25340b3b-3e4c-4ff8-abf6-3e62ec46bd0c | Product name | 1 | 20160603 |
| 2d352c73-a357-4193-a4de-dfdf9a2ac8e4 | Product name | 1 | 20150819 |
| b045ad64-0f28-9a02-2f9b-b34d94fb2278 | Product name | 1 | 20140508 |
| b6082387-f592-1148-0844-bd068fd213fb | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47682-392-12 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 | |
| 47682-392-12 | Triple Antibiotic | 10 in 1 BOX | OINTMENT | 10 | 14 | |
| 47682-392-35 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 | |
| 47682-392-35 | Triple Antibiotic | 144 in 1 BAG | OINTMENT | 144 | 14 | |
| 47682-392-71 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 | |
| 47682-392-71 | Triple Antibiotic | 20 in 1 BOX | OINTMENT | 20 | 14 | |
| 47682-392-73 | Triple Antibiotic | 25 in 1 BOX, UNIT-DOSE | OINTMENT | 25 | 14 | |
| 47682-392-99 | Triple Antibiotic | 0.5 g in 1 PACKET | OINTMENT | 0.5 | 14 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 47682-392 | TRIPLE ANTIBIOTIC (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE) OINTMENT [UNIFIRST FIRST AID CORPORATION] | 13 | Current NDC, Legacy NDC, 8 package rows | 20250210_d7c1a10e-c38d-4ae8-9a27-c07c2208ca84.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Balma Septic Antiseptic Hand Wash | BENZALKONIUM CHLORIDE | Rochester Midland Corporation | 1b8e0a27-dcdd-4d07-b0f2-55cf74a9b528 | 2025-01-10 | Warnings | M004 |
| LX0380 Lynx glacier fresh Antiseptic Hand and Body Wash 6380 | CHLOROXYLENOL | ABC Compounding Co., Inc. | efa3938f-64de-77ba-e053-2a95a90ac840 | 2025-01-10 | Warnings | M004 |
| Bacitracin | BACITRACIN | A-S Medication Solutions | 64aa660d-2d69-48e8-bd0d-4876815d89ff | 2025-01-08 | Warnings | M004 |
| Bacitracin | BACITRACIN | Water-Jel Technologies | 412928a1-3708-4fa8-99c5-aaa2b079cf6e | 2025-01-06 | Warnings | M004 |
| AVON HeXashield Triple Antibiotic with Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCL | Tai Guk Pharm. Co., Ltd. | 8e0cb861-d8aa-1f71-e053-2a95a90aaa88 | 2025-01-01 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Trifecta Pharmaceuticals USA LLC | 087694c2-4b1b-e293-e063-6294a90a961f | 2024-12-31 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE | TRIFECTA PHARMACEUTICALS USA LLC | 0c017b10-29b6-e30f-e063-6294a90a8a3c | 2024-12-31 | Warnings | M004 |
| Triple Antibiotic and Pain Relief | BACITRACIN,NEOMYCIN,POLYMYXINB,PRAMOXINE | Trifecta Pharmaceutical USA LLC | 0bf08cf6-be3f-f9aa-e063-6294a90a4393 | 2024-12-31 | Warnings | M004 |
| Single Antibiotic with Bacitracin | BACITRACIN ZINC | Randob Labs Ltd. | 2a807f1b-986f-a9ea-e063-6394a90aed25 | 2024-12-30 | Warnings | M004 |
| Tripleantibioticapainscaritch | FAMILY WELLNESS BACITRACIN,NEOMYCIN,POLYMYXINB,PRAMOXINEHCL | Trifecta Pharmaceutical USA LLC | 935106c6-8a9e-07fa-e053-2a95a90a2484 | 2024-12-20 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE. | TRIFECTA PHARMACEUTICALS USA LLC | 00c52a31-9bfa-a8bf-e063-6294a90ac4d7 | 2024-12-20 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE | Trifecta Pharmaceuticals Usa Llc | d04b397c-1608-4fd9-be28-ef7285d6a996 | 2024-12-20 | Warnings | M004 |
| Tripleantibioticointmentandpainrelief | FAMILY WELLNESS BACITRACIN,NEOMYCIN,POLYMYXINB,PRAMOXINE | Trifecta Pharmaceutical USA LLC | 91575333-5268-5d8f-e053-2a95a90a7a89 | 2024-12-20 | Warnings | M004 |
| Premier Value Max Strength Antibiotic plus pain relief | PREMIER VALUE NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCL | Pharmacy Value Alliance LLC | 9767821e-054b-3bd3-e053-2a95a90a4b0e | 2024-12-20 | Warnings | M004 |
| Premier Value Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Premier Value Alliance LLC. | ab843664-a1e0-6716-e053-2995a90a2063 | 2024-12-20 | Warnings | M004 |
| Premier Value Bacitracin Zinc | BACITRACIN ZINC | Pharmacy Value Alliance LLC | 99d789be-aa85-0917-e053-2a95a90acd13 | 2024-12-20 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Premier Value Alliance LLC. | ab863d90-1a8f-3c1f-e053-2a95a90aa0a7 | 2024-12-20 | Warnings | M004 |
| Family Wellness First Aid Antibiotic | FAMILY WELLNESS BACITRACIN ZINC, POLYMYXIN B SULFATE | Trifecta Pharmaceuticals USA, LLC | 9157681a-3ed1-096e-e053-2a95a90a05e3 | 2024-12-18 | Warnings | M004 |
| Family Wellness Original | FAMILY WELLNESS BACITRACIN, NEOMYCIN, POLYMYXIN B | Trifecta Pharmaceuticals USA LLC. | 915759af-0d4f-6a87-e053-2a95a90acbd6 | 2024-12-18 | Warnings | M004 |
| Family Wellness Pain Scar Itch | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B, PRAMOXINE HCL | Trifecta Pharmaceutical USA LLC | 9e507ec5-310d-3a21-e053-2a95a90a15a6 | 2024-12-18 | Warnings | M004 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment | PSN | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 14 |
| 204602 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment | SCD | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 14 |
| 204602 | bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment | SY | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 14 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 47682-392-12 | 47682039212 | 0.5 g in 1 PACKET | 0.5 g | Historical | ||||
| 47682-392-35 | 47682039235 | 144 PACKET in 1 BAG (47682-392-35) / .5 g in 1 PACKET | 144 packet | 2017-06-30 | 0000-00-00 | No | No | Current |
| 47682-392-71 | 47682039271 | 0.5 g in 1 PACKET | 0.5 g | Historical | ||||
| 47682-392-73 | 47682039273 | 25 PACKET in 1 BOX, UNIT-DOSE (47682-392-73) / .5 g in 1 PACKET (47682-392-99) | 25 packet | 2016-06-06 | 0000-00-00 | No | No | Current |
| 47682-392-99 | 47682039299 | .5 g in 1 PACKET (47682-392-99) | 2013-04-12 | No | No | Current |